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Peroxisomes are ubiquitous cellular organelles required for speciﬁc pathways of fatty acid oxidation and lipid
synthesis, and until recently their functions in adipocytes have not been well appreciated. Importantly, peroxisomes host many oxygen-consumption reactions and play a major role in generation and detoxiﬁcation of
reactive oxygen species (ROS) and reactive nitrogen species (RNS), inﬂuencing whole cell redox status. Here, we
review recent progress in peroxisomal functions in lipid metabolism as related to ROS/RNS metabolism and
discuss the roles of peroxisomal redox homeostasis in adipogenesis and adipocyte metabolism. We provide a
framework for understanding redox regulation of peroxisomal functions in adipocytes together with testable
hypotheses for developing therapies for obesity and the related metabolic diseases.

1. Introduction
The ability of adipose tissues to dispose of circulating fatty acids
(FA) by storage as triacylglycerols (TAG) or by oxidation has important
metabolic and clinical implications [1]. Increased and dysregulated FA
disposal contributes to the accumulation of potentially harmful FA
metabolites in peripheral organs, which can cause insulin resistance
and cardiometabolic diseases [2]. In addition, adverse remodeling and
expansion of white adipose tissue (WAT) is associated with alterations
in metabolic function and adipokine secretion, and accelerated development of insulin resistance [3]. The expansion of adipose depots can
be driven either by the increase in adipocyte size (hypertrophy) or by
the formation of new adipocytes diﬀerentiated from their precursors
(hyperplasia). Based on diﬀerent adipogenic sites, WAT is usually divided into subcutaneous and visceral depots, which have intrinsically
diﬀerent metabolic functions in maintaining health. The propensity to
generate new adipocytes varies between the diﬀerent adipose depots,
and these processes are diﬀerentially regulated and have diﬀerent
metabolic consequences [4].
Reactive oxygen species (ROS) and reactive nitrogen species (RNS)
are signaling messengers that mediate various biological responses. The

primary ROS/RNS species generated in cells are superoxide radical
(O2%-), hydrogen peroxide (H2O2), hydroxyl radical (%OH), and nitric
oxide radical (%NO) and its derivative peroxynitrite (ONOO−) [5].
Obesity is often associated with an imbalance in oxidation-reduction
(redox) in WAT, which contributes to adipocyte dysfunction and can
inhibit the insulin signaling cascade [6,7]. Mitochondria and peroxisomes are involved in major cellular catabolic pathways that are the
major sources of ROS generation. Mitochondrial ROS signaling in
supporting adipocyte thermogenic identity and function has been demonstrated in numerous animal and cellular models [8]. In contrast,
much less is known about peroxisomes, where FA oxidation is coupled
with the generation of H2O2 and minimal ATP production.
Peroxisomes are dynamic cellular organelles with diverse metabolic
functions. Increase of peroxisomal gene expression and peroxisomal
proliferation were observed during both brown and white adipogenesis
[9]. In adipocytes, peroxisomes generate a variety of signaling molecules that are involved in regulating adipogenesis and adipocyte FA
metabolism. Peroxisomes are named based on their function in producing and detoxifying H2O2 that serves as a cellular redox buﬀering
system [10]. Despite the widespread perception that ROS are toxic byproducts of aerobic metabolism, there is increasing evidence that ROS
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2-OHFA, 2-hydroxy fatty acid; PPARγ, peroxisome proliferator-activated receptor γ; PRDX5, peroxiredoxin 5; PUFA, polyunsaturated fatty acid; RNS, reactive
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dehydrogenase. Treatment of SH-SY5Y cells and astrocytes with phytanic acid results in higher ROS generation, suggesting that the overall
metabolism of pristanic acid contributed to higher cellular oxidative
stress [15]. Another group of FA substrates that undergo α-oxidation is
straight chain 2-hydroxy FA (2-OHFA), (R)-enantiomers of which can
be oxidized by HACL1 [16] and (S)-enantiomers by α-hydroxy acid
oxidases (HAOX1 and HAOX2) leading to H2O2 release [17] (Fig. 1).
Moreover, formate generated by FA α-oxidation can inﬂuence cellular
ROS generation by stimulating mitochondrial superoxide/hydrogen
peroxide release [18].
Additional peroxisomal ROS-producing oxidative enzymes are Damino acid oxidase, D-aspartate oxidase, L-pipecolic acid oxidase,
polyamine oxidase, xanthine oxidase (XDH) and many heme-containing
enzymes [19]. H2O2 and the superoxide anion O2%- are usually generated as byproducts of their catalytic cycle. O2%- reacts rapidly with H2O2
and nitrates to generate hydroperoxide species and the highly oxidative
ONOO−. O2%- can also be dismutated to form H2O2, which is decomposed through the Fenton reaction to %OH. The peroxisomal ROS species react rapidly with lipids to form lipid radicals and lipid peroxidation derivatives and with proteins to instigate damage [20]. Moreover,
peroxisomes contain inducible nitric oxide synthase (iNOS), which
catalyzes the oxidation of L-arginine to generate %NO; targeted disruption of the iNOS gene decreases adipose tissue inﬂammation [21]
(Fig. 2).

species can act as signaling molecules involved in cellular metabolic
functions, including cell proliferation, diﬀerentiation, migration, and
apoptosis [11]. Moreover, accumulating evidence supports that peroxisomal functions as related to ROS metabolism undergo diﬀerential
dynamic regulation in diﬀerent adipose depots. In this paper, we review
the importance of peroxisomal redox signaling in adipogenesis and
adipocyte metabolism.
2. Overview of the metabolic pathways in peroxisomes
Lipid storage and utilization rely on the interplay among the endoplasmic reticulum (ER), mitochondria, peroxisomes and lipid droplets (LD) [12]. Peroxisomes uniquely integrate cellular lipid storage
and removal where FAs can be conjugated with dihydroxyacetone
phosphate (DHAP) to synthesize glycerolipids or be shuttled into oxidative pathways [13]. Peroxisomes are involved in a broad range of
metabolic pathways in humans that include: 1) FA β-oxidation; 2) FA αoxidation; 3) ether lipid synthesis; 4) bile acid synthesis, 5) amino acid
catabolism and 6) glyoxylate detoxiﬁcation [13]. The importance of
peroxisome lipid metabolism in human health is highlighted by the
observations made in patients with Zellweger syndrome, who have a
reduction or absence of functional peroxisomes that cause an accumulation of plasma very-long-chain FA (VLCFA) and branched chain FA
(BCFA) and impaired function in multiple organs [14], including brain
and lung functions [13].

4. Peroxisomal ROS/RNS buﬀering systems
3. ROS-generating pathways in peroxisomes
Multiple antioxidant systems have evolved within peroxisomes to
detoxify ROS/RNS and maintain redox homeostasis. The identiﬁed
peroxisomal antioxidant enzymes include catalase, superoxide dismutases (SODs), peroxidases, peroxiredoxin I and V, and soluble epoxide hydrolase (sEH). The copper-zinc SOD (SOD1) is the cytoplasmic
isoform without an endogenous peroxisomal targeting sequence, but
can be targeted to peroxisomes by using its physiological interaction
partner, copper chaperone of SOD1, as a shuttle [22]. SOD catalyzes the
dismutation of O2%- radical into O2 and H2O2, which are then removed
by catalase and glutathione peroxidase within peroxisomes [23]. Peroxisomal peroxidases remove superoxide anion-induced lipid radicals
and organic hydroperoxide species, and peroxiredoxin I and peroxiredoxin V control peroxide levels [24]. The epoxy FA neutralizing enzyme sEH has been localized in both the cytosol and peroxisomes, and
the monomeric form with disrupting dimerization is preferentially
targeted to peroxisomes [25]. Finally, peroxisomes also contain several
proteases whose functions are linked to ROS-production. Peroxisomal
lon peptidase 2 (LonP2), an ATP-dependent serine protease, is

Peroxisomal FA oxidation shows substrate preference for VLCFA, 2methyl-BCFA (e.g. pristanic acid), 2-hydroxy FA (2-OHFA), long chain
dicarboxylic acid, polyunsaturated FA (PUFA) and precursors of bile
acids. In contrast with mitochondrial FA β-oxidation initiated by acylCoA dehydrogenases and coupled to generation of FADH2, peroxisomal
FA β-oxidation is initiated by fatty acyl-CoA oxidases (ACOXs) with
generation of H2O2. The resulting acetyl-CoA and acyl-CoAs with
shorter chain length are converted to their carnitine conjugates, exported out of peroxisomes and taken up by mitochondria for complete
oxidation (Fig. 1).
Peroxisomal FA α-oxidation is another pathway inﬂuencing cellular
ROS generation. Phytanic acid with a methyl group at the C3 position
prevents its degradation by β−oxidation, but can be converted into
pristanic acid by α oxidation [13]. This reaction is initiated by phytanoyl CoA hydroxylase (PHYH) using O2 as electron acceptor. The resulting 2-hydroxyphytanoyl-CoA is processed sequentially by 2-hydroxyacyl-CoA lyase 1 (HACL1) and by an unknown peroxisomal aldehyde

Fig. 1. Metabolic pathways in peroxisomes and redox regulation. Enzymes in red are known to generate ROS or act as antioxidants. Metabolites in blue act as
non-enzymatic antioxidants. Refer to the text for details. ACOX, acyl-CoA oxidase; Alkyl-G3P, 1-O-alkyl glycerol-3-phosphate; DBP, D-bifunctional protein; DHAP,
dihydroxy acetone phosphate; HAOX, L-hydroxy acid oxidase; HACL1, 2-hydroxyacyl-CoA lyase 1; LBP, L-bifunctional protein; 2-OHFA, 2-hydroxy fatty acid; PHYH,
phytanoyl-CoA 2-hydroxylase; PUFA, poly unsaturated fatty acid; VLCFA, very long chain fatty acid.
2
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Fig. 2. Peroxisomal ROS scavenge system. Red
characters denote ROS/RNS and macromolecular
damaged by ROS. Blue characters denote nonenzymatic antioxidants. Refer to the text for details.
GPX, glutathione peroxidase; GR, glutathione reductase; GSH, reduced glutathione; GSSG, oxidized
glutathione; H2O2, hydrogen peroxide; iNOS, inducible nitric oxide synthase; L%, lipid radical; LOO%,
lipid peroxyl radical; LOOH, lipid peroxide; LOH,
lipid alcohol; LONP2, Lon protease 2; %NO, nitric
oxide radical; O2%-, superoxide radical; OH%, hydroxyl
radical; ONOO−, peroxynitrite; PRDX, peroxiredoxin; PUFA, polyunsaturated fatty acid; SOD, superoxide mutase.

exclusively initiated in peroxisomes [38]. Silencing of Pex16 in 3T3-L1
cells impaired adipocyte diﬀerentiation and cellular TAG stores, which
are rescued by addition of PPARγ agonist rosiglitazone and peroxisomerelated lipid species, highlighting the relevance of peroxisomes for
adipogenesis [39]. Pex7 knockout mice, which are characterized by the
absence of plasmalogens, have markedly reduced WAT and abnormally
small LD within the cytoplasm of individual brown adipocytes [40]. In
contrast, aP2-Pex5 conditional knockout mice showed dysfunctional
WAT with increased fat mass and reduced lipolysis, which may be due
to nonselective inhibition of peroxisomal functions in nervous system
by the aP2 promotor, leading to reduced levels of catecholamine [41].
However, based on normal white adipose and muscle function in NestinPex5 and Wnt-Pex5 knockout mice respectively, it is unlikely that peroxisome absence from the central and peripheral nervous system caused
the observed adipose phenotype. Understanding PEX5 regulation of
adipose expansion in vivo requires additional models of Pex5 deﬁciency
speciﬁc in adipose. Collectively, these data indicate that biogenesis of
peroxisomes provides signaling lipids to promote adipogenesis and
regulate lipogenesis.

implicated in the degradation of damaged proteins by oxidation due to
increased ROS levels, leading to regulation of FA β-oxidation in peroxisomal matrix [26] (Fig. 2).
In addition to the catabolism of various FAs, peroxisomes harbor
metabolic enzymes initiating the synthesis of plasmalogens with vinyl
ether linkage, which can function as non-enzymatic antioxidants [27].
Vinyl ether lipids prevent the propagation of lipid peroxidation [28]
and their deﬁciency makes cells more vulnerable to oxidative stress
[29,30]. Other small molecule antioxidants in peroxisomes include
glutathione and ascorbic acid (vitamin C). Removal of H2O2 is coupled
to the oxidation of GSH to GSSG and the subsequent regeneration of
GSH requires glutathione reductase as well as NADPH (Fig. 2). The
oxidized GSSG may be exported out of peroxisomes for GSH regeneration in cytosol and be re-uptaken to eliminate ROS.
NAD(P)H plays an important role in both peroxisomal ROS generation and elimination. Peroxisomes contain two diﬀerent systems to
regenerate NADPH: the pentose phosphate pathway (PPP) and the
isocitrate dehydrogenase (IDH) pathway. Since NADPH is more abundant than NADH, peroxisomal redox status is often evaluated by assessing the NADPH/NADP+ ratio. NADPH can slowly diﬀuse out of the
peroxisome in vitro, suggesting that peroxisomal NADPH/NADP+ is
able to inﬂuence redox potential in cytosol [31]. In contrast, regeneration of NADH, which is required for continuous β-oxidation in
peroxisomes, is accomplished by a pyruvate-lactate redox shuttle localized on the peroxisomal membrane [32].

6. Redox regulation of adipogenesis
Chronic stimulation of ROS production in adipose during unhealthy
obesity is associated with inhibited insulin signaling and thus impaired
adipogenesis [42]. Peroxisomes may inﬂuence adipogenesis by regulating ROS homeostasis and multiple mechanisms have been proposed
for ROS regulation of adipogenesis. Inhibition of complex I and ATP
synthase increases cellular H2O2 and may act as anti-growth signal on
3T3-L1 preadipocytes to impair their potential to diﬀerentiate [43]. The
preadipocytes acquire resistance against oxidative stress via FoxOregulated expression of ROS-scavenging enzymes during diﬀerentiation
[44] and in vitro study reveals that oxidative stress decreased GLUT4
expression and lipogenesis by diminished binding of C/EBP-dimer to
GLUT4 promoter [45]. This regulation is supported by recent study that
4-hydroxynonenal (4-HNE)-induced oxidative stress impairs the adipogenic capacity of preadipocytes obtained from human subjects [46].
Moreover, cellular redox homeostasis may function through multiple
crucial adipogenic transcriptional factors including C/EBPs, PPARγ,
retinoid X receptor (RXR) as well as PPARγ coactivator 1α (PGC1α),
whose activities are sensitive to their phosphorylation by a myriad of
redox sensitive kinase pathways including c-Jun N-terminal kinase
(JNK), p38-mitogen-activated protein kinase (MAPK), extracellular
signal-regulated kinase (ERK) and protein kinase B (Akt) pathways
[47]. Speciﬁcally, an increase in ROS by treatment with octanoate in
adipocytes was linked to a decrease in TAG synthesis, and reduction of
lipogenic gene expression by inactivation of PPARγ [48].

5. Peroxisomal regulation of adipogenesis
Accumulating evidence supports the importance of peroxisomes in
the regulation of white and brown adipocyte diﬀerentiation (adipogenesis). Adipogenesis relies on a delicate transcriptional program including CCAAT-enhancer binding protein α (C/EBPα) and peroxisome
proliferator-activated receptor (PPARγ) that are also involved in the
regulation of peroxisome proliferation in adipocytes [33]. Peroxisomes
are essential for the metabolism of PUFA, providing natural ligands for
PPARγ [34]. Additionally, 1-O-octadecenyl-2-palmitoyl-3-glycerophosphocholine (18:1e/16:0-GPC) has been identiﬁed as a potential endogenous ligand for PPARγ [35] and monoalkylglycerol ether lipids as a
new class of adipogenic promoters [36]. The peroxisomal ether lipid
synthesis may thus represent a positive feedback loop to sustain the
adipogenic program. In addition to its signaling functions in promoting
adipogenesis, peroxisomes are also signiﬁcantly involved in TAG
synthesis (lipogenesis). In cultured adipocytes, peroxisomes initiated
the synthesis of almost half of the TAG [37] and were closely associated
with LD [12]. Approximately 10–20% of the neutral lipids in LD were
the ether lipid, monoalk(en)yl diacylglycerol, whose synthesis was
3
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adipocyte hypertrophy. Treatment with a SOD mimetics reduces visceral adiposity in mice through a reduction in adipocyte hypertrophy
and adipogenesis, suggesting a causal role for ROS in the response to
increased energy intake and diet-induced obesity [67]. Epoxyeicosatrienoic acid (EET), a type of PUFA that could act as an endogenous
antioxidant, reduces adipogenesis in human mesenchymal stem cells
and mouse 3T3-L1 preadipocytes, and injection of EET leads to reduced
weight gain in obese mice [68]. Deletion of sEH that removes EET results in a signiﬁcant decrease in adipocyte size and a decrease in visceral fat by reprograming of WAT to express mitochondrial and thermogenic genes, a characteristic phenotype of beige fat [69].
Conversely, silencing peroxiredoxin 5 (PRDX5) promotes preadipocytes
to diﬀerentiate into adipocytes and Prdx5 knockout mice exhibit signiﬁcant increase in body weight and enormous fat pads, suggesting ROS
regulation of adipogenic gene expression and adipogenesis [70]. Similarly, catalase knockout mice exhibit an obese phenotype, manifested as
an increase in body weight that becomes more pronounced with age
and develop a pre-diabetic phenotype [71].
In contrast, a recent study using mouse models with peroxisomal
ROS metabolism manipulated speciﬁcally in adipocytes suggests that
oxidative stress inhibits healthy adipose expansion [72]. SOD1 and
catalase over-expression in adipocytes exhibit adipose expansion with
decreased ectopic lipid accumulation and improved insulin sensitivity,
potentially by attenuation of SREBF1-mediated lipogenic transcriptional activities [72]. These data support the idea that peroxisomal
functions in ROS metabolism and adipogenic transcriptional activation
synergistically regulate lipid synthesis and expansion of adipose tissue.
More importantly, it seems that ROS regulation of adipogenesis might
contribute to WAT remodeling and determine its impact on peripheral
tissues. The overall eﬀect of peroxisomal ROS in adipogenesis and
adipocyte functions is determined by temporal regulation of speciﬁc
metabolic pathways of ROS.

On the other hand, accumulating evidence supports that ROS generation seems important for adipocyte diﬀerentiation. Adipogenic differentiation in the 3T3-L1 preadipocytes were stimulated by addition of
H2O2 [49]. Moreover, increased endogenous ROS production is observed even with enhanced expression of ROS-scavenging enzymes [44]
in diﬀerentiating 3T3-L1 cells and in primary human mesenchymal
stem cells undergoing diﬀerentiation into adipocytes [50]. This stimulated ROS generation facilitates adipocyte diﬀerentiation by enhancing
C/EBPβ DNA binding activity and accelerating mitotic clonal expansion
during early stage of diﬀerentiation [51]. Conversely, decrease of intracellular ROS or addition of antioxidants inhibits adipocyte diﬀerentiation [52,53]. Mutual interaction between ROS and insulin signaling has signiﬁcant impact on adipogenesis. ROS generation through
activation of NADPH oxidase homolog -NOX4 induces insulin signaling
and adipogenesis by inhibiting protein phosphatase PIP1B [54]. Alternatively, oxidative stress inhibits expression of the adipogenic suppressor Sirt1, inducing adipogenesis along with adipocyte hypertrophy
in mesenchymal stem cells and mouse pre-adipocytes [55]. Moreover,
Sirt1 activity is sensitive to [NAD+]/[NADH] ratio which impact the
acetylation status and metabolic functions of the adipogenic transcriptional factors [56,57].
The involvement of %NO in regulating adipogenesis and adipocyte
biology has also been studied. %NO is essential for maintaining the
balance between osteoblast and adipocyte lineage diﬀerentiation in
periodontal ligament stem cells via the JNK/MARK signaling pathway.
Increasing the physiological level of %NO with sodium nitroprusside
signiﬁcantly promoted the osteogenic diﬀerentiation capacity, but reduced its adipogenic diﬀerentiation capacity [58]. In contrast, a positive role of %NO in modulating adipogenesis is evidenced in cultured
preadipocytes. %NO level in preadipocytes derived from rat WAT is increased during the early phase of diﬀerentiation and its deprivation
partially abrogated the diﬀerentiation process [59]. S-nitrosylation of
fatty acid synthase induced by %NO increases its activity through dimerization and may contribute to %NO regulation of adipogenesis [60].
Collectively, diﬀerent cellular ROS and RNS may play distinct roles in
diﬀerent stages of adipogenesis [6], whose eﬀects are determined by
the levels and duration of speciﬁc oxidative signaling.

9. Peroxisomal regulation of lipid mobilization
During adipogenesis, peroxisomes increase in number and form
close contact with LD. Moreover, the biogenesis of peroxisomes and LD
occur at the same ER subdomains [73], suggesting their intimate connection and potential functional coupling. Potential peroxisomal regulation of lipolysis has been suggested in peroxisome deﬁcient aP2-Pex5
knockout mice, which have reduced lipolytic rates [41]. In Saccharomyces cerevisiae, peroxisomes can even extend into lipid body cores
and promote the coupling of lipolysis in lipid bodies with peroxisomal
FA oxidation, without passing through the cytosolic compartment [74].
Moreover, the coordination among LD, peroxisomes, and mitochondria
regulated by ATGL-PPARα is important for lipolysis and FA oxidation in
ob/ob mice deﬁcient in Cidea and Cidec [75]. Lipidomics analysis of
diﬀerentiating adipocytes revealed continuous accumulation of odd
chain FAs [76], suggesting a concurrent increase in lipid turnover as
well as the peroxisomal α-oxidation activity.
Level of lipolysis in visceral adipose is higher and declines with age.
In contrast, subcutaneous adipose keeps relatively constant low level.
These depot diﬀerences are not due to diﬀerent oxidative damage or
enzymatic anti-oxidant defense, but may be explained by site variations
in insulin and adrenergic signaling [77]. In humans, both basal and
adrenergic stimulated lipolysis is higher in adipocytes derived from
visceral adipose as compared to cells from subcutaneous depot [78]. In
line with depot speciﬁc regulation of lipolysis, adipocytes from visceral
fat are more insulin-resistant and more sensitive to adrenergic stimulation than subcutaneous WAT.
Cellular redox state inﬂuences lipolysis in adipocytes and peroxisomal redox signaling may contribute to its regulation of lipolysis.
Lactate inhibits lipolysis by blocking the cAMP/PKA signaling cascade
[79] and the NAD+-dependent Sirt1 deacetylase activity promotes fat
mobilization in white adipocytes by repressing PPARγ [80]. Physiological levels of %NO produced in adipose tissue stimulates lipolysis and

7. Depot-dependent redox regulation in adipose
Although brown adipose tissue (BAT) and WAT have comparable
levels of ROS in mice under chow diet, BAT is more sensitive to HFDinduced ROS production [61]. Meanwhile, high fat feeding also increases expression of peroxisomal genes in BAT [9], suggesting potential involvement of peroxisomes in BAT ROS metabolism. Regulation of
ROS metabolism in WAT also shows depot dependency. Mouse visceral
WAT exhibits higher ROS as compared with the subcutaneous depot
and aging induces ROS in visceral, but not in subcutaneous depot [62].
In humans, obesity is associated with lower GSH levels in both WAT
depots, but additional pro-oxidative changes exist only in visceral WAT,
which may be signs of visceral WAT metabolic dysfunction [63]. Cholesterol epoxide increases the expression of α-oxidation related genes in
visceral adipocytes of obese subjects, but not in the subcutaneous adipocytes [64]. Collectively, these observations point out the complex
regulation of oxidative stress in WAT depots and ROS in visceral WAT
seems more sensitive to regulation by aging and obesity. However,
contribution of peroxisomes in the depot-speciﬁc regulation of ROS
metabolism remains to be determined.
8. Peroxisomal redox signaling in adipogenesis
Peroxisome biogenesis and its capacity for lipid metabolism dramatically increase during adipogenesis [65,66], suggesting that peroxisome proliferation can act as a positive feedback circuit to support
adipocyte lipid metabolism and diﬀerentiation. Accumulating evidence
supports that peroxisomal ROS generation promotes adipogenesis and
4
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FA oxidation through both AMPK-dependent and independent mechanisms, whereas high %NO levels inhibit basal as well as adrenergic
stimulated lipolysis [81]. Moreover, iNOS impairs the anti-lipolytic
eﬀect of insulin in postprandial adipocytes, possibly via increased Snitrosylation and inactivation of Akt/phosphodiesterase 3B axis
[82,83].

peroxisomal functions in adipose are not determined by obesity per se,
but may be regulated by speciﬁc pathway leading to adipose expansion
in depot-speciﬁc manner.

10. Peroxisomal regulation of WAT browning and metabolic
remodeling

Mitochondria are important in redox regulation and signaling where
spontaneous leakage of electrons to oxygen from various dehydrogenases and respiratory chain complexes contributes to the generation of ROS. Previous studies suggest that ROS derived from mitochondria are important in the regulation of adipose expansion.
Deletion of p66(Shc), a redox enzyme that generates mitochondrial
ROS, also reduced triglyceride accumulation in adipocytes and in vivo
decreased fat mass and resistance to diet-induced obesity [91]. Prx3 KO
mice had increased fat mass with increased adipogenic transcription
factors and lipogenic gene expression, possibly due to increased oxidative stress as evidenced by mitochondrial protein carbonylation [92].
Moreover, mitochondrial complex III ROS was demonstrated to be a
causal factor in promoting adipocyte diﬀerentiation [50]. In contrast,
adipose speciﬁc deletion of SOD2 increased mitochondrial superoxide
and triggered an adaptive stress response, thereby preventing diet-induced obesity and insulin resistance [93], suggesting diﬀerential regulation of adipose expansion by diﬀerent ROS metabolic pathways.
Peroxisomes cooperate with mitochondria in multiple metabolic
pathways that aﬀect redox-linked physiological processes and dysfunction of one organelle may aﬀect the redox balance and function of
the other [94]. Mitochondrial dysfunction is observed in patients with
X-linked adrenoleukodystrophy (X-ALD) and peroxisome deﬁciency.
Pex5 knockout mice with defective peroxisome biogenesis have altered
mitochondrial ultrastructure with increased mitochondrial ﬁssion and
changes in respiratory chain activity, and Pex13 null MEFs show mitochondrial oxidative stress and altered mitochondrial dynamics [41].
Mitochondrial dysfunction is also observed in ABCD1 deﬁciency as well
as in Zellweger syndrome patients with Pex16 mutation [95]. Increasing peroxisomal FA oxidation boosts mitochondrial FA oxidation
and ROS generation, indicating an intimate relationship between peroxisomes and mitochondria in regulating substrate oxidation and cellular redox status. On the other hand, inhibition of FA transport into
mitochondria by Cpt1 knockout increases adaptive expression of peroxisomal FA oxidation genes, suggesting the presence of a mitochondrial retrograde signaling to regulate peroxisomal FA oxidation [96]. A
recent publication supports a surprising interaction between peroxisomes and mitochondria. Peroxisomes regulate mitochondrial dynamics and thermogenesis, by directing plasmalogens to mitochondria
to mediate mitochondrial ﬁssion [9]. Moreover, mitochondria may act
as dynamic receivers, integrators, and transmitters of peroxisome-derived mediators of oxidative stress, suggesting a potential broader role
for the peroxisome in regulating oxidative stress and adipogenesis
[97,98]. The intimate redox interplay between mitochondria and peroxisomes in regulation of signaling and metabolism makes it diﬃcult to
estimate the relative contribution of peroxisomal ROS as compared to
mitochondrial ROS to these processes.
Peroxisomes oxidize a variety of FAs and generate peroxisomal
H2O2 by ACOX-mediated desaturation, while mitochondria are important for further metabolism of the end-products of peroxisomal β
oxidation which include chain-shortened acyl-CoAs, acetyl-CoA, propionyl-CoA as well as NADH. The transport of acyl-CoAs is achieved by
interconversion with their acyl carnitine counterparts catalyzed by
multiple carnitine acyltransferases and translocase. A recent study
identiﬁes the peroxisome-mitochondrial contact by a proximity detection method based on split ﬂuorophores, and demonstrates its contribution to complete β-oxidation of FAs [99]. Moreover, cargo transport from the mitochondria to peroxisomes can be achieved by
vesicular carriers [100], providing additional mechanism for active
substrate exchange between these two organelles.

12. Interplay between peroxisomes and mitochondria in the
control of cellular redox signaling

Intake of HFD or cold exposure induces the acquisition of thermogenic features in subcutaneous WAT [84]. Characterization of the
transcriptional network responsible for thermogenic fat activation revealed the involvement of PPARγ and PGC1α, which are key regulators
of peroxisomal proliferation [85]. HFD did not increase expression of
peroxisomal genes in WAT [9], arguing against the involvement of
peroxisomes in HFD-induced WAT browning. In contrast, cold exposure
increased the expression of genes involved in peroxisomal biogenesis in
BAT, as well as in subcutaneous WAT, which is highly susceptible to
cold-induced browning [86]. Collectively, these results suggest depotspeciﬁc regulation of peroxisomal signaling may be involved in WAT
browning in response to cold exposure. Although higher ROS level and
more sensitive regulation are observed in visceral fat, which plays
minimal roles in thermogenic activation in response to cold exposure,
whether peroxisomal ROS signaling represents an intrinsic inhibitory
regulator of WAT browning remains elusive.
Depot speciﬁc regulation of adipokine secretion has also been observed. Subcutaneous WAT is the major source of leptin, while visceral
WAT is more capable of generating adiponectin, angiotensinogen,
plasminogen activator inhibitors-1 and pro-inﬂammatory cytokines
[87]. Depot speciﬁc peroxisomal regulation of lipolysis, insulin signaling, glucose and lipid metabolism and adipokine secretion are
mainly unknown due to unavailable depot speciﬁc manipulation of
peroxisomal signaling. However, studies using models of global or
adipose speciﬁc peroxisome deﬁciencies reveal important metabolic
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